Companies: โ€”ยทtotal market cap: โ€”
$ USD
companiesbycap
Menu
Global rankingSuperinvestors
Countries
๐Ÿ‡บ๐Ÿ‡ธUnited States๐Ÿ‡จ๐Ÿ‡ฆCanada๐Ÿ‡ฉ๐Ÿ‡ชGermany๐Ÿ‡ซ๐Ÿ‡ทFrance๐Ÿ‡ฌ๐Ÿ‡งUnited Kingdom๐Ÿ‡จ๐Ÿ‡ญSwitzerland๐Ÿ‡ฎ๐Ÿ‡ณIndia๐Ÿ‡ฏ๐Ÿ‡ตJapan
Categories
๐Ÿ’ปTechnology๐ŸฆFinancials๐Ÿ’ŠHealthcare๐Ÿ›๏ธConsumer Cyclical๐Ÿ“กCommunication๐ŸญIndustrials๐Ÿ›’Consumer DefensiveโšกEnergy
NPCE
NeuroPace Inc. NPCE
$14.97
โ–ผ -1.26% 24H
1.367.3813.4019.4225.442021-042022-082023-112025-032026-06

About

NeuroPace Inc. is a medical technology company specializing in the development of innovative neurostimulation solutions for neurological disorders. The company is primarily known for its RNS System, a groundbreaking implantable device designed to reduce the frequency and severity of epileptic seizures. The system contiโ€ฆ

SectorHealthcare
ExchangeNASDAQ
IndustryMedical Devices
CountryUnited States
Employees220
TickerNPCE

Statistics

Market Cap$507.6M
Revenue (TTM)$100.0M
Net Income-$21.5M
Net Margin-21.5%
EPS$-0.66
P/E-23.94
P/S5.43
P/B37.18
EV/EBITDA-33.71
ROE-111.4%
Dividend Yieldโ€”
Price$14.97

Data: Twelve Data ยท Revenue = mcap / P/S

NeuroPace Inc. (NPCE) โ€” Market Cap, Revenue, Net Income, P/E | companiesbycap